There is also an increasing trend in considering the NANP scaffolds for the controlled immunomodulation, wherein control is provided by several means including but not limited to modifications in the nanoparticle physicochemical properties (e.g., composition, size, shape, sequence complementarity, connectivity), delivery vehicle, dose and route of administration [ 76 , 81 , 82 , 86 , 87 ]. 3.2.
← all excerpts
Nucleic Acid Nanoparticles at a Crossroads of Vaccines and Immunotherapies.
1
—
—